As of January 22, 2025, Generation Bio (GBIO) has a market cap of $63.834 million USD. According to our data, Generation Bio is ranked No.8016 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $63.83 M |
-9.84%
|
Dec 31, 2024 | $70.80 M |
-35.76%
|
Dec 29, 2023 | $0.11 B |
-58.02%
|
Dec 30, 2022 | $0.26 B |
-44.49%
|
Dec 31, 2021 | $0.47 B |
-75.03%
|
Dec 31, 2020 | $1.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Market Cap | = | GBIO Stock Price | * | GBIO Shares Outstanding |
= | $0.96 | * | 66.79 M | |
= | $63.83 M |